Koschei the immortal and anti-aging drugs
- PMID: 25476900
- PMCID: PMC4649836
- DOI: 10.1038/cddis.2014.520
Koschei the immortal and anti-aging drugs
Abstract
In Slavic folklore, Koschei the Immortal was bony, thin and lean. Was his condition caused by severe calorie restriction (CR)? CR deactivates the target of rapamycin pathway and slows down aging. But the life-extending effect of severe CR is limited by starvation. What if Koschei's anti-aging formula included rapamycin? And was rapamycin (or another rapalog) combined with commonly available drugs such as metformin, aspirin, propranolol, angiotensin II receptor blockers and angiotensin-converting enzyme inhibitors.
Figures
Similar articles
-
From rapalogs to anti-aging formula.Oncotarget. 2017 May 30;8(22):35492-35507. doi: 10.18632/oncotarget.18033. Oncotarget. 2017. PMID: 28548953 Free PMC article. Review.
-
Once again on rapamycin-induced insulin resistance and longevity: despite of or owing to.Aging (Albany NY). 2012 May;4(5):350-8. doi: 10.18632/aging.100461. Aging (Albany NY). 2012. PMID: 22683661 Free PMC article. Review.
-
The use of calorie restriction mimetics to study aging.Methods Mol Biol. 2013;1048:95-107. doi: 10.1007/978-1-62703-556-9_8. Methods Mol Biol. 2013. PMID: 23929100
-
Dissecting mammalian target of rapamycin to promote longevity.Rejuvenation Res. 2012 Jun;15(3):334-7. doi: 10.1089/rej.2012.1347. Rejuvenation Res. 2012. PMID: 22758368 Review.
-
Aging and TOR: interwoven in the fabric of life.Cell Mol Life Sci. 2011 Feb;68(4):587-97. doi: 10.1007/s00018-010-0542-0. Epub 2010 Oct 21. Cell Mol Life Sci. 2011. PMID: 20960025 Free PMC article. Review.
Cited by
-
Crosstalk between insulin-like growth factor-1 and angiotensin-II in dopaminergic neurons and glial cells: role in neuroinflammation and aging.Oncotarget. 2016 May 24;7(21):30049-67. doi: 10.18632/oncotarget.9174. Oncotarget. 2016. PMID: 27167199 Free PMC article.
-
Disease or not, aging is easily treatable.Aging (Albany NY). 2018 Nov 17;10(11):3067-3078. doi: 10.18632/aging.101647. Aging (Albany NY). 2018. PMID: 30448823 Free PMC article.
-
Gerosuppression by pan-mTOR inhibitors.Aging (Albany NY). 2016 Dec 30;8(12):3535-3551. doi: 10.18632/aging.101155. Aging (Albany NY). 2016. PMID: 28077803 Free PMC article.
-
From rapalogs to anti-aging formula.Oncotarget. 2017 May 30;8(22):35492-35507. doi: 10.18632/oncotarget.18033. Oncotarget. 2017. PMID: 28548953 Free PMC article. Review.
-
Atlos Labs and the quest for immortality: but can we live longer right now?Oncoscience. 2022 Apr 22;9:13-16. doi: 10.18632/oncoscience.552. eCollection 2022. Oncoscience. 2022. PMID: 35496979 Free PMC article.
References
-
- 1Chang GR, Chiu YS, Wu YY, Chen WY, Liao JW, Chao TH et al. Rapamycin protects against high fat diet-induced obesity in C57BL/6 J mice. J Pharmacol Sci 2009; 109: 496–503. - PubMed
-
- 2Chang GR, Wu YY, Chiu YS, Chen WY, Liao JW, Hsu HM et al. Long-term administration of rapamycin reduces adiposity, but impairs glucose tolerance in high-fat diet-fed KK/HlJ mice. Basic Clin Pharmacol Toxicol 2009; 105: 188–198. - PubMed
-
- 5Rovira J, Marcelo Arellano E, Burke JT, Brault Y, Moya-Rull D, Bañón-Maneus E et al. Effect of mTOR inhibitor on body weight: from an experimental rat model to human transplant patients. Transpl Int 2008; 21: 992–998. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous